shelf(0)

No. 048 · Combos · Peptide Blend

Glow

— Not ranked · combination how tiers work →
  • Not approved as a combo
  • WADA ✗ S0
Compare Cite
Fingerprint combination
Glow (no defined sequence)

Combos are blends of separate compounds, so there is no single sequence. This ring motif is decorative — open a component for its fingerprint.

01

Quick answers

What is Glow?
A skin-focused blend; in this catalog it means GHK-Cu combined with glutathione. Per this catalog: GHK-Cu (copper tripeptide) plus glutathione, sometimes with other peptides. Commercial products sold as “GLOW” vary, and some contain BPC-157 and TB-500 instead.
What is in Glow?
Glow typically combines GHK-Cu and Glutathione. Commercial products vary.
How strong is the evidence for Glow?
It is not ranked. A PubMed search found no published studies of this combination; only reviews mention it. GHK-Cu is supported mostly by lab and topical-skin studies; glutathione has RCTs as a supplement.
Is Glow FDA-approved?
No. Glow is not an approved product; no regulator has reviewed the combination.
Is Glow banned in sport?
Yes. Glow is prohibited in sport by the World Anti-Doping Agency under S0 (non-approved substances).
How does Glow work?
The Glow blend combines GHK-Cu-mediated collagen stimulation and extracellular matrix remodeling with glutathione-driven antioxidant protection and melanin modulation. GHK-Cu activates metalloproteinases for skin remodeling while glutathione neutralizes ROS and inhibits tyrosinase, producing complementary skin-brightening and anti-aging effects.
What is known about the safety of Glow?
Individual components (GHK-Cu, glutathione) have well-documented safety profiles. Combination-specific safety data not available.

Last reviewed · editorial policy · markdown

02

Evidence

  1. D In vitro
  2. C Animal
  3. B Human pilot
  4. A RCT
  5. S Approved

Not ranked: combinations have no published studies of their own. See the components below.

A PubMed search found no published studies of this combination; only reviews mention it. GHK-Cu is supported mostly by lab and topical-skin studies; glutathione has RCTs as a supplement.

Tiers rate the strength of published evidence — not effectiveness, safety, or a recommendation.

03

At a glance

Routes studied
Subcutaneous, Intramuscular Routes used in published research
FDA
Not approved as a combination
WADA
Prohibited · S0 Non-approved substances
04

Overview

A skin-focused blend; in this catalog it means GHK-Cu combined with glutathione. Commercial products sold as “Glow” vary, and some instead combine GHK-Cu with BPC-157 and TB-500. Promoted for collagen support, oxidative protection, and skin radiance.

Research status Proprietary blend with variable composition; no published studies of the combination; evidence exists only for individual components

05

Mechanism

The Glow blend combines GHK-Cu-mediated collagen stimulation and extracellular matrix remodeling with glutathione-driven antioxidant protection and melanin modulation. GHK-Cu activates metalloproteinases for skin remodeling while glutathione neutralizes ROS and inhibits tyrosinase, producing complementary skin-brightening and anti-aging effects.

06

Effects reported in research

These outcomes are attributed to the individual components. The combination itself has not been studied.

  • Enhanced skin luminosity and tone
  • Increased collagen production
  • Reduced oxidative skin damage
  • Improved skin hydration and elasticity
07

Safety & unknowns

Individual components (GHK-Cu, glutathione) have well-documented safety profiles. Combination-specific safety data not available. Proprietary formulation varies by provider. Side effects expected to mirror those of individual components. Not FDA-approved as a combination.

Unknowns. The combination itself has not been studied; interactions between its components are unknown.

Informational only — not medical advice. peptidemeta publishes no dosing, protocols, or sourcing. Talk to a qualified clinician about any treatment decision.

08

Studies [2]

  1. Review 2015

    GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration

    Pickart L, Vasquez-Soltero JM, Margolina A. BioMed Research International

    Review of the GHK-Cu component, covering its proposed roles in wound healing, collagen and glycosaminoglycan synthesis, and metalloproteinase regulation.

    [pubmed] [doi]

  2. Clinical trial 2015

    Randomized controlled trial of oral glutathione supplementation on body stores of glutathione

    Richie JP Jr, Nichenametla S, Neidig W, et al. European Journal of Nutrition

    RCT on the glutathione component alone: 6 months of oral glutathione raised body glutathione stores; it did not study the blend.

    [pubmed] [doi]

09

Components

GHK-Cu Tier B · Small human studies B Glutathione Tier A · Controlled human trials A
11

Status sources

Sources behind the tier, regulatory status, sequence and dates on this page.

12

Cite this entry

$ cite --format=apa

peptidemeta. (2026). Glow. In peptidemeta: The peptide library, ranked by evidence. Retrieved November 8, 2026, from https://peptidemeta.com/p/glow/

$ cite --format=bibtex 
@misc{peptidemeta-glow,
  title = {Glow},
  author = {{peptidemeta}},
  year = {2026},
  howpublished = {\url{https://peptidemeta.com/p/glow/}},
  note = {Accessed 2026-11-08}
}

Accessed date reflects when you opened this page. Cite primary studies for scientific claims.

esc
↑↓ navigate ↵ open